-
1
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002; 418: 191-195.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
2
-
-
33845333359
-
The extracellular release of HMGB1 during apoptotic cell death
-
Bell CW, Jiang W, Reich CF et al. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol, 2006; 291: C1318-C1325.
-
(2006)
Am J Physiol Cell Physiol
, vol.291
-
-
Bell, C.W.1
Jiang, W.2
Reich, C.F.3
-
3
-
-
51649111202
-
High-mobility group box-1 in ischemia-reperfusion injury of the heart
-
Andrassy M, Volz HC, Igwe JC et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation, 2008; 117: 3216-3226.
-
(2008)
Circulation
, vol.117
, pp. 3216-3226
-
-
Andrassy, M.1
Volz, H.C.2
Igwe, J.C.3
-
4
-
-
67650257147
-
Increased serum HMGB1 is related to the severity of coronary artery stenosis
-
Hu X, Jiang H, Bai Q et al. Increased serum HMGB1 is related to the severity of coronary artery stenosis. Clin Chim Acta, 2009; 406: 139-142.
-
(2009)
Clin Chim Acta
, vol.406
, pp. 139-142
-
-
Hu, X.1
Jiang, H.2
Bai, Q.3
-
5
-
-
80051553550
-
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction
-
Andrassy M, Volz HC, Riedle N et al. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med, 2011; 270: 245-253.
-
(2011)
J Intern Med
, vol.270
, pp. 245-253
-
-
Andrassy, M.1
Volz, H.C.2
Riedle, N.3
-
6
-
-
84863613842
-
Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation
-
Zhao D, Wang Y, Xu Y. Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation. Int J Cardiol, 2012; 158: 471-472.
-
(2012)
Int J Cardiol
, vol.158
, pp. 471-472
-
-
Zhao, D.1
Wang, Y.2
Xu, Y.3
-
8
-
-
84862798064
-
HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury
-
Hu X, Fu W, Jiang H. HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury. Int J Cardiol, 2012; 155: 489-489.
-
(2012)
Int J Cardiol
, vol.155
, pp. 489
-
-
Hu, X.1
Fu, W.2
Jiang, H.3
-
9
-
-
0033304603
-
The glucagon-like peptides
-
Kieffer TJ, and Habener JF. The glucagon-like peptides. Endocr Rev, 1999; 20: 876-913.
-
(1999)
Endocr Rev
, vol.20
, pp. 876-913
-
-
Kieffer, T.J.1
Habener, J.F.2
-
10
-
-
12144260853
-
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
-
Bose AK, Mocanu MM, Carr RD et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes, 2005; 54: 146-151.
-
(2005)
Diabetes
, vol.54
, pp. 146-151
-
-
Bose, A.K.1
Mocanu, M.M.2
Carr, R.D.3
-
11
-
-
33845293219
-
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
-
Sokos GG, Nikolaidis LA, Mankad S et al. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail, 2006; 12: 694-699.
-
(2006)
J Card Fail
, vol.12
, pp. 694-699
-
-
Sokos, G.G.1
Nikolaidis, L.A.2
Mankad, S.3
-
12
-
-
38149083367
-
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
-
Sonne DP, Engstrom T, Treiman M. Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul Pept, 2008; 146: 243-249.
-
(2008)
Regul Pept
, vol.146
, pp. 243-249
-
-
Sonne, D.P.1
Engstrom, T.2
Treiman, M.3
-
13
-
-
84860638209
-
The Cardiovascular effects of GLP-1 receptor agonists
-
Okerson T, Chilton RJ. The Cardiovascular effects of GLP-1 receptor agonists. Cardiovasc Ther, 2012; 30: e146-e155.
-
(2012)
Cardiovasc Ther
, vol.30
-
-
Okerson, T.1
Chilton, R.J.2
-
14
-
-
85027916650
-
Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression
-
Cai Y, Hu X, Yi B et al. Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression. Mol Biol Rep, 2012; 39: 10705-10711.
-
(2012)
Mol Biol Rep
, vol.39
, pp. 10705-10711
-
-
Cai, Y.1
Hu, X.2
Yi, B.3
-
15
-
-
84857072431
-
GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats
-
Wu L, Olverling A, Huang Z et al. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats. Clin Sci, 2012; 122: 375-384.
-
(2012)
Clin Sci
, vol.122
, pp. 375-384
-
-
Wu, L.1
Olverling, A.2
Huang, Z.3
-
16
-
-
84873687814
-
Exendin-4 attenuates ischemia--induced ventricular arrhythmias in rats
-
Zhang K, Wu Y, Zhao L et al. Exendin-4 attenuates ischemia--induced ventricular arrhythmias in rats. Cardiol J, 2013; 20: 29-33.
-
(2013)
Cardiol J
, vol.20
, pp. 29-33
-
-
Zhang, K.1
Wu, Y.2
Zhao, L.3
-
17
-
-
84855192732
-
Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats
-
Hu X, Cui B, Zhou X et al. Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Mol Biol Rep, 2012; 19: 227-231.
-
(2012)
Mol Biol Rep
, vol.19
, pp. 227-231
-
-
Hu, X.1
Cui, B.2
Zhou, X.3
-
18
-
-
58949084130
-
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury
-
Timmers L, Henriques JPS, de Kleijn DPV et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol, 2009; 53: 501-510.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 501-510
-
-
Timmers, L.1
Henriques, J.P.S.2
de Kleijn, D.P.V.3
-
19
-
-
77953543903
-
Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats
-
Hu X, Zhou X, He B et al. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol, 2010; 638: 84-89.
-
(2010)
Eur J Pharmacol
, vol.638
, pp. 84-89
-
-
Hu, X.1
Zhou, X.2
He, B.3
-
20
-
-
0032777020
-
Apoptosis in myocardial ischemia-reperfusion
-
Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci, 1999; 68: 412-426.
-
(1999)
Ann N Y Acad Sci
, vol.68
, pp. 412-426
-
-
Gottlieb, R.A.1
Engler, R.L.2
-
21
-
-
33847775295
-
Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1
-
Tang D, Shi Y, Kang R et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol, 2007; 81: 741-747.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 741-747
-
-
Tang, D.1
Shi, Y.2
Kang, R.3
-
22
-
-
36548999695
-
HMGB1 release induced by liver ischemia involves toll-like receptor 4-depedent reactive oxygen species production and calcium-mediated signaling
-
Tsung A, Klune JR, Zhang X et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4-depedent reactive oxygen species production and calcium-mediated signaling. J Exp Med, 2007; 204: 2913-2923.
-
(2007)
J Exp Med
, vol.204
, pp. 2913-2923
-
-
Tsung, A.1
Klune, J.R.2
Zhang, X.3
|